HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
3.430
+0.260 (8.20%)
At close: Aug 28, 2026, 4:00 PM EDT
3.300
-0.130 (-3.79%)
After-hours: Aug 28, 2026, 7:38 PM EDT
HCW Biologics Revenue
HCW Biologics had revenue of $135.57K in the quarter ending June 30, 2026, with 1,969.74% growth. This brings the company's revenue in the last twelve months to $6.72M, up 707.02% year-over-year. In the year 2025, HCW Biologics had annual revenue of $54.23K, down -97.89%.
Revenue (ttm)
$6.72M
Revenue Growth
+707.02%
P/S Ratio
0.94
Revenue / Employee
$192,034
Employees
35
Market Cap
6.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 54.23K | -2.51M | -97.89% |
| Dec 31, 2024 | 2.57M | -275.00K | -9.68% |
| Dec 31, 2023 | 2.84M | -3.88M | -57.72% |
| Dec 31, 2022 | 6.72M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
HCWB News
- 2 days ago - HCW Biologics Registration statement: Registration filing - Filings
- 5 days ago - HCW Biologics' TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells - GlobeNewsWire
- 10 days ago - HCW Biologics files to sell 1.24M shares of common stock for holders - TheFly
- 10 days ago - HCW Biologics Registration statement: Registration filing - Filings
- 16 days ago - HCW Biologics Earnings release: Q2 2026 - Filings
- 16 days ago - HCW Biologics Quarterly report: Q2 2026 - Filings
- 16 days ago - HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results - GlobeNewsWire
- 4 weeks ago - HCW Biologics announces pricing of $1.6M private placement - TheFly